Stay updated on Consolidation Pembrolizumab in Stage III NSCLC Clinical Trial

Sign up to get notified when there's something new on the Consolidation Pembrolizumab in Stage III NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Consolidation Pembrolizumab in Stage III NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.5 to v3.6.6 on the page, signaling a newer version of the page. This change is a metadata update rather than a modification to the study content or details.
    Difference
    0.1%
    Check dated 2026-08-31T17:23:51.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The revision tag on the page updated from v3.6.4 to v3.6.5. This reflects an administrative update to the study record rather than a change to study details.
    Difference
    0.0%
    Check dated 2026-08-10T13:23:57.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.4, indicating a small update to the page version. No study data or displayed details were changed.
    Difference
    0.0%
    Check dated 2026-07-27T06:19:35.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The page footer revision label changed from v3.6.2 to v3.6.3, indicating a version update to the ClinicalTrials.gov study details page. This update does not alter the study data or how a user interacts with the page.
    Difference
    0.0%
    Check dated 2026-07-05T12:27:12.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The page's revision label updated from v3.6.0 to v3.6.2, indicating a new release of the page. This appears to be a technical revision rather than a change to the study details or content visible to users.
    Difference
    0.0%
    Check dated 2026-06-28T08:18:09.000Z thumbnail image
  9. Check
    93 days ago
    Change Detected
    Summary
    The page adds user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and standardizes the Intervention/Treatment heading; it also updates the revision label to v3.6.0 and notes that recruitment is closed with a 'No longer looking for participants' statement.
    Difference
    0.4%
    Check dated 2026-06-14T05:08:04.000Z thumbnail image

Stay in the know with updates to Consolidation Pembrolizumab in Stage III NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Consolidation Pembrolizumab in Stage III NSCLC Clinical Trial page.